Scheme 1
Dexamethasone inhibites osteogenic differentiation and induces bone loss by inhibiting the activation of dopamine receptor D1 via downregulating the ERK1/2 signaling pathway
Scheme 1 | Molecular Medicine
Dexamethasone inhibites osteogenic differentiation and induces bone loss by inhibiting the activation of dopamine receptor D1 via downregulating the ERK1/2 signaling pathway
Molecular Medicine